Status:
RECRUITING
Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19)
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to confirm or rule out the residual presence and viability of SARS- CoV-2 in the respiratory tract and lung parenchyma of patients previously infected with SARS-CoV-2. Presen...
Detailed Description
The investigators will collect residuary lung tissue after medically indicated pulmonary resections at the Thoracic Surgery Department of University Hospitals Leuven. More specifically the investigato...
Eligibility Criteria
Inclusion
- Patient requires medically indicated pulmonary resection
- Informed consent
Exclusion
- Active SARS-CoV-2 infection/COVID-19
- No informed consent
Key Trial Info
Start Date :
January 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04775134
Start Date
January 31 2021
End Date
December 31 2025
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Belgium, 3000